FDA Will Believe it When They See It - Virtually


Replacing even a fraction of real patients in clinical trials with virtual patients embracing digital technologies, the FDA wants to build a playbook for an in will be an innovation that will be welcomed by all. In their latest step towards silico clinical trial, which could be a game changer for medical device makers, drug companies, and clinicians.

Document Details

Reference

BM_Oct_19_7

Authors

Levine. S

Language

English

Type

Magazine Article

Date

2019-10-01

Organisations

Dassault Systèmes

Region

Global

 NAFEMS Member Download



This site uses cookies that enable us to make improvements, provide relevant content, and for analytics purposes. For more details, see our Cookie Policy. By clicking Accept, you consent to our use of cookies.